Clinical Updates
Drug approvals, guideline changes, and treatment advances
University of Queensland Drug Targets Immune Receptor, Offering Hope for Motor Neuron Disease
Researchers at the University of Queensland have developed a novel drug that activates a previously difficult-to-target immune receptor, a breakthrough…
Editor's Top Picks
High benchmark scores mask critical brittleness in health AI systems, Nature Medicine study reveals
A Nature Medicine study reveals that large language models achieve high scores on health AI benchmarks yet fail adversarial stress…
Submit Your Paper →
More form Clinical Updates
Listeria Outbreak in Pregnant Women Linked to Ready-to-Eat Sandwiches Reveals Food Safety Gaps
Seven pregnant women across four states developed listeriosis from contaminated ready-to-eat sandwiches, highlighting critical gaps…
PCOS Officially Renamed to PMOS After Decade of Research With 14,000 Participants
Polycystic ovary syndrome has been renamed to polycystic ovary metabolic syndrome after a decade-long consultation…
Strong nurse-patient relationships reduce psychiatric hospital stays, UK study finds
New research shows that strong therapeutic relationships between psychiatric nurses and patients, formed within the…
Teclistamab Shows Strong Response Rates in Earlier-Line Multiple Myeloma Treatment
Phase 3 trial shows teclistamab extends progression-free survival by 7.3 months compared with standard treatments…
Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access
Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations. FDA submission planned…